How Two Pharmacists Figured Out That Decongestants Don’t Work
A loophole in FDA processes means older drugs such as those in oral decongestants weren’t properly tested. Here’s how we learned the most popular one doesn’t work
Pharmaceuticals
New Class of Antibiotics Discovered Using AI
A deep-learning algorithm helped identify new compounds that are effective against antibiotic-resistant infections in mice, opening the door to AI-guided drug discovery
Weight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart Disease
The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers
Popular Weight-Loss Drugs Come with Side Effects
Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro
Should Insurance Cover Wegovy, Ozempic and Other New Weight-Loss Drugs?
Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone
95 Percent of Penicillin Allergy Diagnoses Are Wrong. A New Test Could Help
A simplified penicillin allergy test could help reduce false positives, but doctors face challenges in using it
A Popular Decongestant Doesn’t Work. What Does?
The popular decongestant phenylephrine is not effective, an FDA panel found. Here’s what to use instead.
Why There’s a Serious Cancer Drug Shortage, and How to Fix It
The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market
‘Budget Ozempic’ Weight-Loss Trend Raises Safety Concerns
The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused
What Biden’s Drug Price Negotiations Mean for You
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
Weight-Loss Drug Also Protects against Heart Disease. What Happens Next?
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial
How Advocates Pushed Big Pharma to Cut Tuberculosis Drug Prices
The world’s best TB drug was too expensive for sufferers—until advocates and a YouTube star changed almost everything